Identification of novel pancreatic adenocarcinoma cell-surface targets by gene expression profiling and tissue microarray

Biochemical Pharmacology

Volumn 80, Issue 5, 2010, Pages 748-754

  Morse, David L ^a   Balagurunathan, Yoga ^b   Hostetter, Galen ^b   Trissal, Maria ^c   Tafreshi, Narges K ^a   Burke, Nancy ^a   Lloyd, Mark ^a   Enkemann, Steven ^a   Coppola, Domenico ^a   Hruby, Victor J ^d   Gillies, Robert J ^a   Han, Haiyong ^b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d University of Arizona   (United States)

Author keywords

Biomarker; Cancer; Cell surface; Expression profiling; Imaging

Indexed keywords

MESSENGER RNA;

ARTICLE; CELL SURFACE; GENE EXPRESSION; GENE IDENTIFICATION; GENE TARGETING; HUMAN; IMMUNOHISTOCHEMISTRY; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; TISSUE MICROARRAY;

ADENOCARCINOMA; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; PANCREATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE ARRAY ANALYSIS;

EID: 77954214387     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2010.05.018     Document Type: Article

References (31)

1. Von Hoff D.D., Evans B.D., Hruban R.H. Pancreatic cancer 2005, Jones and Bartlett Publishers, Sudbury.
2. Loos M., Kleeff J., Friess H., Buchler M.W. Surgical treatment of pancreatic cancer. Ann N Y Acad Sci 2008, 1138:169-180.
3. Nieto J., Grossbard M.L., Kozuch P. Metastatic pancreatic cancer 2008: is the glass less empty?. Oncologist 2008, 13:562-576.
4. Klapman J., Malafa M.P. Early detection of pancreatic cancer: why, who, and how to screen. Cancer Control 2008, 15:280-287.
5. Hoimes C.J., Moyer M.T., Saif MW Biomarkers for early detection and screening in pancreatic cancer. Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009. JOP 2009, 10:352-356.
6. Khan G.N., di Magliano M.P., Simeone D.M. New frontiers in pancreatic cancer research. Surg Oncol Clin N Am 2010, 19:431-451.
7. Goggins M. Identifying molecular markers for the early detection of pancreatic neoplasia. Semin Oncol 2007, 34:303-310.
8. Temming K., Schiffelers R.M., Molema G., Kok R.J. RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature. Drug Resist Updat 2005, 8:381-402.
9. Haubner R., Weber W.A., Beer A.J., Vabuliene E., Reim D., Sarbia M., et al. Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD. PLoS Med 2005, 2:e70.
10. Beer A.J., Haubner R., Wolf I., Goebel M., Luderschmidt S., Niemeyer M., et al. PET-based human dosimetry of 18F-galacto-RGD, a new radiotracer for imaging alpha v beta3 expression. J Nucl Med 2006, 47:763-769.
11. Goldenberg D.M., Sharkey R.M. Advances in cancer therapy with radiolabeled monoclonal antibodies. Q J Nucl Med Mol Imag 2006, 50:248-264.
12. Jhanwar Y.S., Divgi C. Current status of therapy of solid tumors. J Nucl Med 2005, 46(Suppl 1):141S-150S.
13. Balagurunathan Y., Morse D.L., Hostetter G., Shanmugam V., Stafford P., Shack S., et al. Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer. Mol Cancer Ther 2008, 7:3071-3080.
14. Kononen J., Bubendorf L., Kallioniemi A., Barlund M., Schraml P., Leighton S., et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998, 4:844-847.
15. Andersen C.L., Hostetter G., Grigoryan A., Sauter G., Kallioniemi A. Improved procedure for fluorescence in situ hybridization on tissue microarrays. Cytometry 2001, 45:83-86.
16. Mousses S., Bubendorf L., Wagner U., Hostetter G., Kononen J., Cornelison R., et al. Clinical validation of candidate genes associated with prostate cancer progression in the CWR22 model system using tissue microarrays. Cancer Res 2002, 62:1256-1260.
17. Watanabe A., Cornelison R., Hostetter G. Tissue microarrays: applications in genomic research. Expert Rev Mol Diagn 2005, 5:171-181.
18. Morse D.L., Carroll D., Weberg L., Borgstrom M.C., Ranger-Moore J., Gillies R.J. Determining suitable internal standards for mRNA quantification of increasing cancer progression in human breast cells by real-time reverse transcriptase polymerase chain reaction. Anal Biochem 2005, 342:69-77.
19. Sahay G., Alakhova D.Y., Kabanov AV Endocytosis of nanomedicines. J Control Rel 2010.
20. O'Brien C., Cavet G., Pandita A., Hu X., Haydu L., Mohan S., et al. Functional genomics identifies ABCC3 as a mediator of taxane resistance in HER2-amplified breast cancer. Cancer Res 2008, 68:5380-5389.
21. Yao N., Xiao W., Wang X., Marik J., Park S.H., Takada Y., et al. Discovery of targeting ligands for breast cancer cells using the one-bead one-compound combinatorial method. J Med Chem 2009, 52:126-133.
22. Brown KC Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications. Curr Pharm Des 2009.
23. Matijevic T., Pavelic J. Toll-like receptors: cost or benefit for cancer?. Curr Pharm Des 2009.
24. Meng G., Grabiec A., Vallon M., Ebe B., Hampel S., Bessler W., et al. Cellular recognition of tri-/di-palmitoylated peptides is independent from a domain encompassing the N-terminal seven leucine-rich repeat (LRR)/LRR-like motifs of TLR2. J Biol Chem 2003, 278:39822-39829.
25. Sallustio F., De Benedictis L., Castellano G., Zaza G., Loverre A., Costantino V., et al. TLR2 plays a role in the activation of human resident renal stem/progenitor cells. FASEB J 2010, 24:514-525.
26. Taylor T., Kim Y.J., Ou X., Derbigny W., Broxmeyer H.E. Toll like receptor 2 mediates proliferation, survival, NFkappaB translocation, and cytokine mRNA expression in LIF-maintained mouse embryonic stem cells. Stem Cells Dev 2010.
27. Zhang Q., Iwakuma N., Sharma P., Moudgil B.M., Wu C., McNeill J., et al. Gold nanoparticles as a contrast agent for in vivo tumor imaging with photoacoustic tomography. Nanotechnology 2009, 20:395102.
28. Matsumura Y., Kataoka K. Preclinical and clinical studies of anticancer agent-incorporating polymer micelles. Cancer Sci 2009, 100:572-579.
29. O'Connor A.E., Gallagher W.M., Byrne A.T. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem Photobiol 2009, 85:1053-1074.
30. Wainwright M. Photodynamic therapy: the development of new photosensitisers. Anticancer Agents Med Chem 2008, 8:280-291.
31. Xu L., Vagner J., Josan J., Lynch R.M., Morse D.L., Baggett B., et al. Enhanced targeting with heterobivalent ligands. Mol Cancer Ther 2009, 8:2356-2365.